Program Description
Collaborative practice
agreements (CPAs) can be significantly impactful opportunities for oncology
pharmacists to expand their roles and contribute to patient care. Several
studies have documented the benefits of CPAs in enhancing patient safety,
facilitating more timely access to care, and generating greater efficiencies
and cost-effectiveness in oncology pharmacy practice. However, the
implementation of CPAs is often hindered by significant challenges and
inconsistencies, including a lack of standardized state-level and federal
policies, which creates a fragmented and confusing regulatory environment for
pharmacists. Oncology pharmacists need to understand the essential elements of
CPAs not only within their geographic practice areas but also within their
physical practice sites. The 2025 Directions in Oncology Pharmacy keynote
address will provide a comprehensive overview of how oncology pharmacists may
participate in CPAs in a variety of oncology practice settings. The essential
components of a CPA as well as examples of specific variations of CPAs will be
reviewed. Key discussion points will center on specific institutional protocols
needed to effectively operate under the CPA and assess what services oncology
pharmacists can provide, what resources are available, and how to best
integrate them into the existing team.
Target Audience: Oncology Pharmacist
Type of Activity: Knowledge
Release date: December
5, 2025
Expiration date: December
5, 2026
Learner
level: Foundational,
Intermediate
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Review essential components of a collaborative practice agreement (CPA) for oncology pharmacists
- Discuss current policies affecting CPAs, including key enablers and limitations
- Outline strategies to ensure adherence to CPA policies and to measure the impact of pharmacist-led interventions
Eve Segal, PharmD, BCOP
Lead Clinical Pharmacist, Oncology
Fred Hutchinson Cancer Center
Seattle, WA
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-25-395-H03-P. The activity is available for CE credit through December 5, 2026.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with ineligible companies to disclose:
Faculty
Eve Segal, PharmD, BCOP
Pharmacy Times Continuing Education™ Planning
Staff—Jim Palatine, RPh, MBA; Daphne
Davis, PharmD, BCOP; Victoria Chirdo; Susan Pordon; Brianna Winters; and Chloe Taccetta have no
relevant financial relationships with ineligible companies to disclose.
Any relevant financial relationships listed for these individuals have been mitigated.
At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not
constitute any form of professional advice or referral. Discussions concerning
drugs, dosages, and procedures may reflect the clinical experience of the
author(s) or they may be derived from the professional literature or other
sources and may suggest uses that are investigational in nature and not
approved labeling or indications. Participants are encouraged to refer to
primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms